» Articles » PMID: 27401947

The Clinical Symptoms of Parkinson's Disease

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2016 Jul 13
PMID 27401947
Citations 424
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, the clinical features of Parkinson's disease, both motor and non-motor, are described in the context of the progression of the disease. Also briefly discussed are the major treatment strategies and their complications. Parkinson's disease is a slowly progressing neurodegenerative disorder, causing impaired motor function with slow movements, tremor and gait and balance disturbances. A variety of non-motor symptoms are common in Parkinson's disease. They include disturbed autonomic function with orthostatic hypotension, constipation and urinary disturbances, a variety of sleep disorders and a spectrum of neuropsychiatric symptoms. This article describes the different clinical symptoms that may occur and the clinical course of the disease. This article is part of a special issue on Parkinson disease.

Citing Articles

A novel integrative multimodal classifier to enhance the diagnosis of Parkinson's disease.

Zhou X, Parisi L, Huang W, Zhang Y, Huang X, Youseffi M Brief Bioinform. 2025; 26(2).

PMID: 40062615 PMC: 11891661. DOI: 10.1093/bib/bbaf088.


Exploration of novel phytochemicals as α-synuclein aggregation inhibitors in the context of Parkinson's disease therapy: an in-silico approach.

Gupta G, Joshi D, Narayan G, Sharma S In Silico Pharmacol. 2025; 13(1):37.

PMID: 40061632 PMC: 11885716. DOI: 10.1007/s40203-025-00330-8.


Using Healthcare Redesign to Identify Medication Management Issues in Parkinson's Disease.

Williams S, Iannuzzi M, Prior S Pharmacy (Basel). 2025; 13(1).

PMID: 39998011 PMC: 11859038. DOI: 10.3390/pharmacy13010013.


RGS10 attenuates systemic immune dysregulation induced by chronic inflammatory stress.

Jernigan J, Staley H, Baty Z, Bolen M, Gomes B, Holt J J Neuroinflammation. 2025; 22(1):49.

PMID: 39994765 PMC: 11852585. DOI: 10.1186/s12974-024-03322-1.


Neuroprotective effect of NSCs-derived extracellular vesicles in Parkinson's disease models.

Diaz Reyes M, Gatti S, Delgado Ocana S, Ortega H, Banchio C Sci Rep. 2025; 15(1):6092.

PMID: 39971975 PMC: 11839983. DOI: 10.1038/s41598-025-87238-7.